| W Atkinson, T A Sheldon, N
Shaath, P J Whorwell. Irritable Bowel Syndrome. View
PDF |
Tanja Spöttl, Ralf Schierl,
Martin Hausmann, Andrea Dirmeier, Jürgen
Schölmerich, Hans Herfarth, Gerhard Rogler.
Crohn's disease View
PDF |
| G. H. S. Vance, C. A. Thornton,
T.N. Bryant, J.A. Warner and J.O. Warner. Asthma View
PDF |
Akerblom HK, Vaarala O, Hyoty H, Ilonen J, Knip M. Environmental
factors in the etiology of type 1 diabetes.
Am J Med Genet 2002; 115: 18-29
Barbeau WE. Interactions between dietary proteins
and the human system: implications for oral tolerance
and food-related diseases. Adv Exp Med Biol
1997; 415: 183-193
Bellmann K, Kolb H, Hartmann B, Rothe H, Rowsell P,
Rastegar S, Burg-hardt K, Scott FW. Intervention
in autoimmune diabetes by targeting the gut immune system. Int
J Immu-nopharmacol 1997; 19: 573-577
Bindslev-Jensen C, Skov PS, Madsen F, Poulsen LK. Food
allergy and food intolerance - what is the difference? Ann
Allergy 1994; 72: 317-320
Borst SE, Bagby GJ. Neutralisation of tumour
necrosis factor reverses age-induced impairment of
insulin responsiveness in skeletal muscle of Sprague-Dawley
rats. Metabolism 2002; 51: 1061-1064
Cavaillon JM. Cytokines in inflammation. C
R Seances Biol Fil 1995; 189: 531-544
Coppack SW. Pro-inflammatory cytokines and adipose
tissue. Proc Nutr Soc 2001; 60: 349-356
Groop LC. Insulin resistance: the fundamental
trigger of type 2 diabetes. Diabetes Obes
Metab 1999; 1: S1-S7
Groux H, Powrie F. Regulatory T cells and inflammatory
bowel disease. Immunol Today 1999; 20: 442-446
Hanson SJ, Gause W, Natelson B. Detection of
immunologically significant factors for chronic fatigue
syndrome using neural-network classifiers. Clin
Diagn Lab Immunol 2001; 8: 658-662
Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo
RB. The expression of tumour necrosis factor
in human adipose tissue. Regulation by obesity, weight
loss, and relationship to lipoprotein lipase. J
Clin Invest 1995; 95: 2111-2119
Lester MR, Hofer MF, Gately M, Trumble A, Leung DY. Down-regulating
effects of IL-4 and IL-10 on the IFN-gamma response
in atopic dermatitis. J Immunol 1995; 154:
6174-6181
Patton JS, Shepard HM, Wilking H, Lewis G, Aggarwal
BB, Eessalu TE, Gavin LA, Grunfeld C. Interferons
and tumour necrosis factors have similar catabolic effects
on 3T3-L1 cells. Proc Natl Acad Sci USA 1986;
83: 8313-8317
Reaven GM. Role of insulin resistance in human
disease. Diabetes1988; 37: 1595-1607
Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber
S, Mac-Dermott RP, Raedler A. Enhanced secretion
of tumour necrosis factor a, IL-6 and IL- 1b by isolated
lamina propria mono-nuclear cells from patients with
ulcerative Colitis and Crohn’s disease. Clin
Exp Immunol 1993; 94: 174-181
Schafer ML. On the history of the concept neurasthenia
and its modern variants chronic-fatigue-syndrome, fibromyalgia
and multiple chemical sensitivities. Fortschr
Neurol Psychiatry 2002; 70: 570-582
Secundolfo M, de Magistris L, Fiandra R, Caserta L,
Bellatta M, Tartaglione MT, Riegler G, Biagi F, Corazza
GR, Carratu R. Intestinal permeability in Crohn’s
disease patients and their first degree relatives. Dig
Liver Dis 2001; 33: 680-685
Targan SR. Biology of inflammation in Crohn’s
disease: mechanisms of action of anti-TNF-a therapy. Can
J Gastroenterol 2000; 14: S13-16
Tsuji NM, Mizumachi K, Kuriaski J. Interleukin-10-secreting
Peyer’s patch cells are responsible for active
suppression in low-dose oral tolerance. Immunology
2001; 4: 458-464
Vahasalo P, Petays T, Knip M, Miettinen A, Saukkonen
T, Karjalainen J, Savilathi E, Ackerblom HK. Relation
between antibodies to islet cell antigens, other auto
antigens and cows milk proteins in diabetic children
and unaffected siblings at the clinical manifestation
of IDDM. The Childhood Diabetes in Finland Study
Group. Autoimmunity 1996; 23: 165-174
White KP, Speechley M, Harth M, Ostbye T. Co-existence
of chronic fatigue syndrome with fibromyalgia syndrome
in the general population. Scand J Rheumatol
2000; 29: 44-51
Zinman B, Hanley AJG, Harris SB, Kwan J, Fantus IG. Circulating
tumour necrosis factor-a concentrations in a native
Canadian population with high rates of type 2 diabetes. J
Clin Endocrinol Metab 1999; 84: 272-278
Back to the top?
